Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

IFN-β Improves Sepsis-related Alveolar Macrophage Dysfunction and Postseptic Acute Respiratory Distress Syndrome-related Mortality.

Hiruma T, Tsuyuzaki H, Uchida K, Trapnell BC, Yamamura Y, Kusakabe Y, Totsu T, Suzuki T, Morita S, Doi K, Noiri E, Nakamura K, Nakajima S, Yahagi N, Morimura N, Chang K, Yamada Y.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):45-55. doi: 10.1165/rcmb.2017-0261OC.

PMID:
29365277
2.

Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.

Chen GH, Reddy RC, Newstead MW, Tateda K, Kyasapura BL, Standiford TJ.

J Immunol. 2000 Dec 1;165(11):6496-503.

3.

Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.

Shindo Y, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CD, Green JM, Morre M, Bochicchio GV, Hotchkiss RS.

J Leukoc Biol. 2017 Feb;101(2):543-554. doi: 10.1189/jlb.4A1215-581R. Epub 2016 Sep 14.

4.

Acute downregulation of miR-199a attenuates sepsis-induced acute lung injury by targeting SIRT1.

Liu Y, Guan H, Zhang JL, Zheng Z, Wang HT, Tao K, Han SC, Su LL, Hu D.

Am J Physiol Cell Physiol. 2018 Apr 1;314(4):C449-C455. doi: 10.1152/ajpcell.00173.2017. Epub 2018 Jan 10.

5.

Low-dose interferon-α treatment improves survival and inflammatory responses in a mouse model of fulminant acute respiratory distress syndrome.

Kudo D, Uno K, Aoyagi T, Akahori Y, Ishii K, Kanno E, Maruyama R, Kushimoto S, Kaku M, Kawakami K.

Inflammation. 2013 Aug;36(4):812-20. doi: 10.1007/s10753-013-9607-1.

PMID:
23407996
6.

Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia.

Högner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, Walmrath HD, Bodner J, Gattenlöhner S, Lewe-Schlosser P, Matrosovich M, Seeger W, Lohmeyer J, Herold S.

PLoS Pathog. 2013 Feb;9(2):e1003188. doi: 10.1371/journal.ppat.1003188. Epub 2013 Feb 28. Erratum in: PLoS Pathog. 2016 Jun;12(6):e1005716.

7.

Early-phase Innate Immune Suppression in Murine Severe Sepsis Is Restored with Systemic Interferon-β.

Kusakabe Y, Uchida K, Yamamura Y, Hiruma T, Totsu T, Tamai Y, Tsuyuzaki H, Hasegawa K, Chang K, Yamada Y.

Anesthesiology. 2018 Jul;129(1):131-142. doi: 10.1097/ALN.0000000000002185.

PMID:
29601323
8.

IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.

Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ.

J Immunol. 1999 Jan 1;162(1):392-9.

9.

IL-27 controls sepsis-induced impairment of lung antibacterial host defence.

Cao J, Xu F, Lin S, Song Z, Zhang L, Luo P, Xu H, Li D, Zheng K, Ren G, Yin Y.

Thorax. 2014 Oct;69(10):926-37. doi: 10.1136/thoraxjnl-2014-205777. Epub 2014 Jul 29. Erratum in: Thorax. 2015 Mar;70(3):243.

PMID:
25074706
10.

Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction.

Pène F, Zuber B, Courtine E, Rousseau C, Ouaaz F, Toubiana J, Tazi A, Mira JP, Chiche JD.

J Immunol. 2008 Dec 15;181(12):8513-20.

11.

Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury.

McHugh WM, Russell WW, Fleszar AJ, Rodenhouse PE, Rietberg SP, Sun L, Shanley TP, Cornell TT.

Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L903-L912. doi: 10.1152/ajplung.00007.2016. Epub 2016 Sep 16.

12.

Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.

Hoogerwerf JJ, Leendertse M, Wieland CW, de Vos AF, de Boer JD, Florquin S, van der Poll T.

Am J Respir Crit Care Med. 2011 Apr 1;183(7):932-40. doi: 10.1164/rccm.201006-0934OC. Epub 2010 Oct 19.

PMID:
20959556
14.

Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.

Song Z, Zhang J, Zhang X, Li D, Wang H, Xu X, Xu W, Yin Y, Cao J.

J Infect Dis. 2015 May 15;211(10):1616-27. doi: 10.1093/infdis/jiu668. Epub 2014 Dec 8.

PMID:
25489003
15.

Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.

Chimenti L, Camprubí-Rimblas M, Guillamat-Prats R, Gomez MN, Tijero J, Blanch L, Artigas A.

Thromb Haemost. 2017 Nov;117(11):2125-2134. doi: 10.1160/TH17-05-0347. Epub 2017 Nov 30.

16.

Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.

Delaval M, Boland S, Solhonne B, Nicola MA, Mornet S, Baeza-Squiban A, Sallenave JM, Garcia-Verdugo I.

Part Fibre Toxicol. 2015 Jan 21;12:1. doi: 10.1186/s12989-014-0078-9.

17.

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.

Bellingan G, Maksimow M, Howell DC, Stotz M, Beale R, Beatty M, Walsh T, Binning A, Davidson A, Kuper M, Shah S, Cooper J, Waris M, Yegutkin GG, Jalkanen J, Salmi M, Piippo I, Jalkanen M, Montgomery H, Jalkanen S.

Lancet Respir Med. 2014 Feb;2(2):98-107. doi: 10.1016/S2213-2600(13)70259-5. Epub 2013 Dec 23.

PMID:
24503265
18.
19.

Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome.

Jacobs RF, Tabor DR, Burks AW, Campbell GD.

Am Rev Respir Dis. 1989 Dec;140(6):1686-92.

PMID:
2604296
20.

Supplemental Content

Support Center